Pain-Related Behavior and Pain Perception Associated with Intraosseous Local Anesthesia (QuickSleeper 5®) in Pediatric Patients: A Randomized Controlled Clinical Trial
Abstract
Background: Managing pain during dental procedures is crucial, particularly for children, as pain can induce anxiety. Local anesthesia is the most anxiety-inducing procedure in pediatric patients. Consequently, this study aimed to assess and compare the pain-related behaviors and perceptions associated with two anesthesia techniques for children: traditional local anesthesia and intraosseous local anesthesia administered via the QuickSleeper 5® system. Methods: A split-mouth randomized clinical trial was conducted involving 33 children aged 4–9 years. Each participant received both traditional local anesthesia and intraosseous local anesthesia with QuickSleeper 5 across two visits. Pain-related behaviors were evaluated by calibrated pediatric dentists through video recordings, and pain perceptions were assessed using the Wong–Baker Faces Pain Rating Scale. Heart rate measurements offered objective insights into patients’ anxiety; finally, the time needed to administer anesthesia was recorded. Results: This study found no statistically significant differences between traditional local anesthesia and intraosseous local anesthesia with QuickSleeper 5 regarding pain perception, heart rate, or pain-related behaviors, indicating that both techniques are effective at minimizing discomfort. However, QuickSleeper 5 demonstrated a significantly shorter administration time, enhancing the procedural efficiency of pediatric dentistry. Conclusions: The QuickSleeper 5 system is a valuable…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 33 participants or records.
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.